These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 6430252)
1. Gold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria. Wilson AP; Prouse PJ; Gumpel JM Ann Rheum Dis; 1984 Jun; 43(3):511-2. PubMed ID: 6430252 [TBL] [Abstract][Full Text] [Related]
5. Membranous glomerulonephritis as a complication of oral gold therapy. Plaza JJ; Herrero G; Barat A; Loutaif JJ; Hernando L; Vallado P; Oliva H Ann Intern Med; 1982 Oct; 97(4):563-4. PubMed ID: 6812474 [No Abstract] [Full Text] [Related]
6. Failure of sodium aurothiomalate and triethyl phosphine gold to cause renal tubular injury in rheumatoid arthritis: implications for the aetiology of gold-related nephropathy. Crisp AJ; Coughlan RJ; Clark B; Mackintosh D; Panayi GS; Sweny P; Hopper J; Varghese Z Clin Rheumatol; 1983 Sep; 2(3):273-6. PubMed ID: 6432404 [TBL] [Abstract][Full Text] [Related]
7. Auranofin (SK + F 39162) induced enterocolitis in rheumatoid arthritis. A case report. Jarner D; Nielsen AM Scand J Rheumatol; 1983; 12(3):254-6. PubMed ID: 6414080 [TBL] [Abstract][Full Text] [Related]
8. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy]. Rainer F; Ulreich A Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058 [No Abstract] [Full Text] [Related]
9. Auranofin: experience to date. Blodgett RC Am J Med; 1983 Dec; 75(6A):86-9. PubMed ID: 6419601 [TBL] [Abstract][Full Text] [Related]
10. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis. Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596 [TBL] [Abstract][Full Text] [Related]
11. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation. Manthorpe R; Hørbov S; Sylvest J; Vinterberg H Scand J Rheumatol; 1986; 15(1):13-22. PubMed ID: 3083505 [TBL] [Abstract][Full Text] [Related]
12. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review. Horton RJ Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044 [TBL] [Abstract][Full Text] [Related]
13. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects]. Goebel KM; Storck U Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234 [TBL] [Abstract][Full Text] [Related]
14. Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study. van Riel PL; van de Putte LB; Gribnau FW; Macrae KD Clin Rheumatol; 1984 Mar; 3 Suppl 1():51-6. PubMed ID: 6432414 [TBL] [Abstract][Full Text] [Related]
15. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis. Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923 [TBL] [Abstract][Full Text] [Related]